NYT: July 24, 2019. World wide recall of Allergan textured breast implants will reduce risk of cancer but won’t eliminate it, we tell The New York Times.Read More »
NBC: July 24, 2019. NCHR president explains to NBC News why recalling Allergan textured breast implants is “an important step” to improve patients’ safety.Read More »
ICIJ: July 24, 2019. Women considering breast implants shouldn’t have to worry that they will cause cancer, NCHR president tells investigative journalists at ICIJ.Read More »
Joe Carlson and Jim Spencer, Star Tribune; June 21, 2019 The U.S. Food and Drug Administration on Friday published millions of previously undisclosed reports of problems and post-surgical complications involving medical devices, including reports on implantable cardiac defibrillators, pacemaker electrodes and dental implants. The roughly 6 million reports released Friday cover a wide array of devices in […]Read More »
Washington Post: June 21, 2019. The Food and Drug Administration on Friday approved sales of a new drug intended to enhance sexual desire in women.
Marketed as Vyleesi, also known as bremelanotide, the medication is a shot that comes in a push pen device, but it isn’t much more effective than placebo. And is it safe?